Clinical Trials Directory

Trials / Sponsors / Shenzhen TargetRx Co., Ltd.

Shenzhen TargetRx Co., Ltd.

Industry · 14 registered clinical trials5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingTGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia - Chronic Phase
Phase 32026-04-01
CompletedTGRX-678 Pharmacokinetic Mass Balance
Chronic Myeloid Leukemia
Phase 12025-07-07
CompletedTGRX-678 Phase I Oral Pharmacokinetic Study
Chronic Myeloid Leukemia
Phase 12024-11-24
RecruitingTGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Chronic Myeloid Leukemia, Accelerated Phase CML
Phase 22024-07-15
RecruitingTGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
Non Small Cell Lung Cancer, Advanced Solid Tumor, Hematologic Malignancy
Phase 12024-07-08
RecruitingTGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Chronic Myelogenous Leukemia
Phase 12024-07-02
CompletedTGRX-326 Pharmacokinetic Mass Balance
Non Small Cell Lung Cancer
Phase 12024-06-26
RecruitingTGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia
Phase 1 / Phase 22024-03-06
CompletedTGRX-326 Pharmacokinetic Drug Interaction
Non Small Cell Lung Cancer
Phase 12024-03-04
Active Not RecruitingTGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 32023-12-14
CompletedTGRX-326 Pharmacokinetic Food Effect Bioavailability Study
Non Small Cell Lung Cancer
Phase 12023-12-13
Active Not RecruitingTGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 22023-01-18
Active Not RecruitingTGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 12021-04-23
Active Not RecruitingTGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
Chronic Myelogenous Leukemia
Phase 12021-03-29